Effects of statins on serum n-3 to n-6 polyunsaturated fatty acid ratios in patients with coronary artery disease

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 18, Issue 4, 2013, Pages 320-326

  Nozue, Tsuyoshi ^a   Yamamoto, Shingo ^b   Tohyama, Shinichi ^c   Fukui, Kazuki ^d   Umezawa, Shigeo ^e   Onishi, Yuko ^e   Kunishima, Tomoyuki ^f   Sato, Akira ^g   Nozato, Toshihiro ^h   Miyake, Shogo ⁱ   Takeyama, Youichi ^j   Morino, Yoshihiro ^k   Yamauchi, Takao ^l   Muramatsu, Toshiya ^m   Hibi, Kiyoshi ⁿ   Michishita, Ichiro ^a  

^a Yokohama Sakae Kyosai Hospital   (Japan)

^b Tsurumi Nishiguchi Hospital   (Japan)

^c Yokohama Seamen's Insurance Hospital   (Japan)

^d Kanagawa Prefectural Cardiovascular and Respiratory Diseases Center Hospital   (Japan)

^e Hiratsuka Kyosai Hospital   (Japan)

^f TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g YOKOSUKA KYOSAI HOSPITAL   (Japan)

^h NATIONAL HOSPITAL ORGANIZATION   (Japan)

ⁱ Ebina General Hospital   (Japan)

^j SHOWA UNIVERSITY   (Japan)

^k TOKAI UNIVERSITY   (Japan)

^l TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^m SAISEIKAI YOKOHAMASHI TOBU HOSPITAL   (Japan)

ⁿ YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

more..

Author keywords

coronary artery disease; polyunsaturated fatty acids; statin

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; ARACHIDONIC ACID; C REACTIVE PROTEIN; CHOLESTEROL; DOCOSAHEXAENOIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; LINOLENIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PITAVASTATIN; TRIACYLGLYCEROL;

AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DRUG EFFECT; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS;

CORONARY ARTERY DISEASE; POLYUNSATURATED FATTY ACIDS; STATIN;

AGED; ALPHA-LINOLENIC ACID; ARACHIDONIC ACID; CHOLESTEROL, LDL; CORONARY ARTERY DISEASE; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; JAPAN; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PRAVASTATIN; PROSPECTIVE STUDIES; QUINOLINES;

EID: 84879223888     PISSN: 10742484     EISSN: 19404034     Source Type: Journal    
DOI: 10.1177/1074248412473202     Document Type: Article

References (25)

1. Iso H, Kobayashi M, Ishihara J, et al. Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan public health center-based (JPHC) study cohort i. Circulation. 2006 ; 113 (2). 195-202
2. Mozaffarian D, Lemaitre RN, Kuller LH, Burke GL, Tracy RP, Siscovick DS. Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the cardiovascular health study. Circulation. 2003 ; 107 (10). 1372-1377
3. Yokoyama M, Origasa H, Matsuzaki M, et al. Japan EPA lipid intervention study (JELIS) Investigators. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet. 2007 ; 369 (9567). 1090-1098
4. Rissanen T, Voutilainen S, Nyyssönen K, Lakka TA, Salonen JT. Fish oil-derived fatty acids, docosahexaenoic acid and docosapentaenoic acid, and the risk of acute coronary events: the Kuopio ischaemic heart disease risk factor study. Circulation. 2000 ; 102 (22). 2677-2679
5. Domei T, Yokoi H, Kuramitsu S, et al. Ratio of serum n-3 to n-6 polyunsaturated fatty acids and the incidence of major adverse cardiac events in patients undergoing percutaneous coronary intervention. Circ J. 2012 ; 76 (2). 423-429
6. Matsuzaki M, Yokoyama M, Saito Y, et al. JELIS Investigators. Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease. Circ J. 2009 ; 73 (7). 1283-1290
7. Cannon CP, Braunwald E, McCabe CH, et al. Pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004 ; 350 (15). 1495-1504
8. LaRosa JC, Grundy SM, Waters DD, et al. Treating to new targets (TNT) investigators. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med. 2005 ; 352 (14). 1425-1435
9. Ridker PM, Genest J, Boekholdt SM, et al. HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial. Lancet. 2010 ; 376 (9738). 333-339
10. Nozue T, Yamamoto S, Tohyama S, et al. Statin treatment for coronary artery plaque composition based on intravascular ultrasound radiofrequency data analysis. Am Heart J. 2012 ; 163 (2). 191-199
11. Shishehbor MH, Zhang R, Medina H, et al. Systemic elevations of free radical oxidation products of arachidonic acid are associated with angiographic evidence of coronary artery disease. Free Radic Biol Med. 2006 ; 41 (11). 1678-1683
12. Tretjakovs P, Kalnins U, Dabina I, et al. Nitric oxide production and arachidonic acid metabolism in platelet membranes of coronary heart disease patients with and without diabetes. Med Princ Pract. 2003 ; 12 (1). 10-16
13. Dwyer JH, Allayee H, Dwyer KM, et al. Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N Engl J Med. 2004 ; 350 (1). 29-37
14. von Schacky C.. Prophylaxis of atherosclerosis with marine omega-3 fatty acids. A comprehensive strategy. Ann Intern Med. 1987 ; 107 (6). 890-899
15. Calder PC.. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr. 2006 ; 83 (suppl 6). 1505S - 1519S
16. Rapp JH, Connor WE, Lin DS, Porter JM. Dietary eicosapentaenoic acid and docosahexaenoic acid from fish oil. Their incorporation into advanced human atherosclerotic plaques. Arterioscler Thromb. 1991 ; 11 (4). 903-911
17. Thies F, Garry JM, Yaqoob P, et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet. 2003 ; 361 (9356). 477-485
18. Cawood AL, Ding R, Napper FL, et al. Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability. Atherosclerosis. 2010 ; 212 (1). 252-259
19. Nakamura N, Hamazaki T, Ohta M, et al. Joint effects of HMG-CoA reductase inhibitors and eicosapentaenoic acids on serum lipid profile and plasma fatty acid concentrations in patients with hyperlipidemia. Int J Clin Lab Res. 1999 ; 29 (1). 22-25
20. Harris JI, Hibbeln JR, Mackey RH, Muldoon MF. Statin treatment alters serum n-3 and n-6 fatty acids in hypercholesterolemic patients. Prostaglandins Leukot Essent Fatty Acids. 2004 ; 71 (4). 263-269
21. Kurisu S, Ishibashi K, Kato Y, et al. Effects of lipid-lowering therapy with strong statin on serum polyunsaturated fatty acid levels in patients with coronary artery disease [published online December 21, 2011]. Heart Vessels. 2011 ;:
22. Jula A, Marniemi J, Rönnemaa T, Virtanen A, Huupponen R. Effects of diet and simvastatin on fatty acid composition in hypercholesterolemic men: a randomized controlled trial. Arterioscler Thromb Vasc Biol. 2005 ; 25 (9). 1952-1959
23. Das UN. Beneficial actions of statins in the reduction of atrial fibrillation and stabilization and regression of coronary plaques: but how and why?. Circ J. 2011 ; 75 (1). 224-225
24. Nordoy A, Bonaa KH, Sandset PM, Hansen JB, Nilsen H. Effect of omega-3 fatty acids and simvastatin on hemostatic risk factors and postprandial hyperlipemia in patients with combined hyperlipemia. Arterioscler Thromb Vasc Biol. 2000 ; 20 (1). 259-265
25. Seppänen-Laakso T, Vanhanen H, Laakso I, Kohtamäki H, Viikari J. Replacement of margarine on bread by rapeseed and olive oils: effects on plasma fatty acid composition and serum cholesterol. Ann Nutr Metab. 1993 ; 37 (4). 161-174